Clinical Trial Update: An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates [Phase 1]

View source ↗

Summary

This open-label Phase 1 study evaluated the safety and pharmacokinetics of repeated-dose micafungin in neonates with Candida infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Candida | Phase 1 | Status: COMPLETED